BNP Paribas Financial Markets’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Buy |
2,571
+609
| +31% | +$13.3K | ﹤0.01% | 3405 |
|
|
2025
Q1 | $36.3K | Sell |
1,962
-1,338
| -41% | -$24.7K | ﹤0.01% | 3551 |
|
|
2024
Q4 | $87.9K | Sell |
3,300
-18,665
| -85% | -$497K | ﹤0.01% | 3358 |
|
|
2024
Q3 | $516K | Buy |
21,965
+5,397
| +33% | +$127K | ﹤0.01% | 2145 |
|
|
2024
Q2 | $307K | Buy |
16,568
+11,909
| +256% | +$221K | ﹤0.01% | 2253 |
|
|
2024
Q1 | $83.2K | Buy |
+4,659
| New | +$83.2K | ﹤0.01% | 2816 |
|